JP2020516684A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020516684A5 JP2020516684A5 JP2020505949A JP2020505949A JP2020516684A5 JP 2020516684 A5 JP2020516684 A5 JP 2020516684A5 JP 2020505949 A JP2020505949 A JP 2020505949A JP 2020505949 A JP2020505949 A JP 2020505949A JP 2020516684 A5 JP2020516684 A5 JP 2020516684A5
- Authority
- JP
- Japan
- Prior art keywords
- lactobacillus
- zeae
- buchneri
- cell
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000186660 Lactobacillus Species 0.000 claims description 49
- 229940039696 lactobacillus Drugs 0.000 claims description 48
- 241000186679 Lactobacillus buchneri Species 0.000 claims description 30
- 241000577554 Lactobacillus zeae Species 0.000 claims description 30
- 239000000706 filtrate Substances 0.000 claims description 29
- 239000012228 culture supernatant Substances 0.000 claims description 28
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 17
- 206010061218 Inflammation Diseases 0.000 claims description 12
- 230000004054 inflammatory process Effects 0.000 claims description 12
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 8
- 208000017520 skin disease Diseases 0.000 claims description 7
- 208000023275 Autoimmune disease Diseases 0.000 claims description 6
- 241000831743 Lactobacillus parafarraginis Species 0.000 claims description 6
- 206010003246 arthritis Diseases 0.000 claims description 6
- 208000027866 inflammatory disease Diseases 0.000 claims description 6
- 230000002757 inflammatory effect Effects 0.000 claims description 6
- 230000029663 wound healing Effects 0.000 claims description 6
- 206010017964 Gastrointestinal infection Diseases 0.000 claims description 5
- 208000019836 digestive system infectious disease Diseases 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 210000005095 gastrointestinal system Anatomy 0.000 claims description 5
- 208000026721 nail disease Diseases 0.000 claims description 5
- 230000001737 promoting effect Effects 0.000 claims description 5
- 201000004624 Dermatitis Diseases 0.000 claims description 4
- 208000007882 Gastritis Diseases 0.000 claims description 4
- 208000015181 infectious disease Diseases 0.000 claims description 4
- 208000024891 symptom Diseases 0.000 claims description 4
- 206010017533 Fungal infection Diseases 0.000 claims description 3
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 3
- 208000031888 Mycoses Diseases 0.000 claims description 3
- 241000209191 Acetobacter fabarum Species 0.000 claims description 2
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 2
- 208000011231 Crohn disease Diseases 0.000 claims description 2
- 206010061304 Nail infection Diseases 0.000 claims description 2
- 201000004681 Psoriasis Diseases 0.000 claims description 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims description 2
- 241000509461 [Candida] ethanolica Species 0.000 claims description 2
- 206010000496 acne Diseases 0.000 claims description 2
- 208000010668 atopic eczema Diseases 0.000 claims description 2
- 206010021198 ichthyosis Diseases 0.000 claims description 2
- 208000002551 irritable bowel syndrome Diseases 0.000 claims description 2
- 208000018937 joint inflammation Diseases 0.000 claims description 2
- 201000008482 osteoarthritis Diseases 0.000 claims description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 2
- 206010040872 skin infection Diseases 0.000 claims description 2
- 239000011021 lapis lazuli Substances 0.000 claims 3
- 210000001503 joint Anatomy 0.000 claims 1
- 238000000034 method Methods 0.000 description 34
- 239000002609 medium Substances 0.000 description 12
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 206010005913 Body tinea Diseases 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 3
- 208000002474 Tinea Diseases 0.000 description 3
- 201000010618 Tinea cruris Diseases 0.000 description 3
- 208000027503 bloody stool Diseases 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 201000003875 tinea corporis Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 241000589220 Acetobacter Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017901320 | 2017-04-11 | ||
| AU2017901320A AU2017901320A0 (en) | 2017-04-11 | Methods for the treatment of inflammation and inflammatory conditions | |
| AU2017902271A AU2017902271A0 (en) | 2017-06-15 | Methods for the treatment of inflammation and inflammatory conditions | |
| AU2017902271 | 2017-06-15 | ||
| PCT/AU2018/050326 WO2018187838A1 (en) | 2017-04-11 | 2018-04-11 | Methods for the treatment of inflammation and inflammatory conditions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020516684A JP2020516684A (ja) | 2020-06-11 |
| JP2020516684A5 true JP2020516684A5 (enExample) | 2021-07-26 |
| JP7494110B2 JP7494110B2 (ja) | 2024-06-03 |
Family
ID=63792160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505949A Active JP7494110B2 (ja) | 2017-04-11 | 2018-04-11 | 炎症及び炎症性疾患の治療法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20200376047A1 (enExample) |
| EP (1) | EP3609515A4 (enExample) |
| JP (1) | JP7494110B2 (enExample) |
| CN (1) | CN110753553A (enExample) |
| AU (1) | AU2018251616B2 (enExample) |
| CA (1) | CA3059453A1 (enExample) |
| SG (1) | SG11201908857QA (enExample) |
| WO (1) | WO2018187838A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109172613B (zh) * | 2018-08-14 | 2022-04-22 | 景岳生物科技(中国)有限公司 | 含乳杆菌死菌培养物的皮肤外用组合物及其于促进伤口愈合及降低疤痕产生的用途 |
| EP3863656A4 (en) * | 2018-10-10 | 2022-06-29 | Servatus Ltd | Methods of treatment of inflammatory conditions and associated infections |
| GB201905386D0 (en) * | 2019-04-16 | 2019-05-29 | Probi Ab | Probiotic compositions and uses thereof |
| EP3815700A1 (en) * | 2019-10-30 | 2021-05-05 | Biomillenia SAS | Medical compositions and their use in treating inflammatory bowel disease |
| US12329181B2 (en) * | 2020-02-28 | 2025-06-17 | Terragen Holdings Limited | Microbial feed supplement composition and method |
| CN115551524A (zh) * | 2020-03-31 | 2022-12-30 | 赛瓦图斯有限公司 | 用于炎性肠病的组合疗法 |
| CN111733110B (zh) * | 2020-07-17 | 2021-10-22 | 佛山市朗芯生物科技有限公司 | 副干酪乳杆菌及其在制备治疗溃疡性结肠炎药物中的应用 |
| CN114470007B (zh) * | 2020-11-13 | 2024-10-18 | 葡萄王生技股份有限公司 | 含乳酸菌发酵产物之皮肤创伤外用组合物及其用途 |
| WO2022115907A1 (en) * | 2020-12-01 | 2022-06-09 | Servatus Ltd | Methods for improving sleep quality |
| AU2021397808A1 (en) * | 2020-12-09 | 2023-07-06 | Servatus Ltd | Combination therapy for inflammatory disorders of the joints |
| CN112522160B (zh) * | 2020-12-24 | 2022-05-10 | 广东省科学院微生物研究所(广东省微生物分析检测中心) | 一株具有抗病毒能力的发酵乳杆菌pv22及其应用 |
| KR102268128B1 (ko) * | 2021-02-09 | 2021-06-22 | 주식회사 락토메이슨 | 모유 유래 신규한 락토바실러스 루테리 lm1071 균주, 및 상기 균주 또는 이의 배양물을 포함하는 월경전 증후군 완화용 조성물 |
| CN114456967B (zh) * | 2021-10-14 | 2022-10-04 | 命之源(杭州)生物科技有限公司 | 一种酵母、乳酸菌联合菌、培育方法及其应用 |
| WO2023097375A1 (en) * | 2021-12-02 | 2023-06-08 | Servatus Ltd | Methods for the treatment of constipation |
| KR102879081B1 (ko) * | 2023-03-28 | 2025-11-05 | 제이에스바이오컴퍼니 주식회사 | 락토바실러스 파카라제이 및 락토바실러스 부크네리를 포함하는 유산균 배양액 제조 방법 및 이를 이용한 피부 개선 기능성 원료 제조 방법 |
| WO2025054048A1 (en) * | 2023-09-08 | 2025-03-13 | MarvelBiome, Inc. | Methods and uses of microbiome compositions, components, or metabolites for treating lipid and cholesterol metabolism associated diseases, disorders, and conditions |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100553646C (zh) * | 2000-10-06 | 2009-10-28 | 雀巢产品股份有限公司 | 用乳酸菌微生态制剂调节皮肤免疫系统 |
| US20030175305A1 (en) * | 2002-01-08 | 2003-09-18 | Garner Bryan E. | Compositions and methods for inhibiting pathogenic growth |
| US20040208863A1 (en) | 2003-01-30 | 2004-10-21 | James Versalovic | Anti-inflammatory activity from lactic acid bacteria |
| AU2013201442B2 (en) * | 2005-09-28 | 2014-10-30 | Nordic Rebalance A/S | Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors |
| BRPI0719431A2 (pt) | 2006-12-01 | 2013-12-03 | Organobalance Gmbh | Composição, kit, uso de uma combinação de microorganismo, e, método para a produção da composição ou do kit. |
| KR100858840B1 (ko) * | 2007-03-05 | 2008-09-17 | (주)네오팜 | 신규 유산균 균주 및 이를 포함하는 유산균 제제 |
| EP2205259B1 (en) * | 2007-10-02 | 2014-12-10 | Institut National de la Recherche Scientifique | Mpm (malleable protein matrix) for use in the treatment of arthritis, obesity, insulin resistance, type 2 diabetes, autoimmune disease, hypertension, and hyperlipidemia |
| WO2012039615A2 (en) * | 2010-09-21 | 2012-03-29 | Winclove Bio Industries B.V. | Commensal rat ileum bacterium (crib) |
| US20140147427A1 (en) * | 2011-06-08 | 2014-05-29 | Organobalance Gmbh | Spray-Dried Lactobacillus Stems/Cells and the Use of Same Against Helicobacter Pylori |
| CA2854362C (en) | 2011-11-04 | 2018-10-16 | International Marketing Partnerships Pty Ltd | Microbial inoculants and fertilizer compositions comprising the same |
| US8906668B2 (en) * | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| DK2988763T3 (da) | 2013-04-23 | 2023-10-16 | Terragen Holdings Ltd | Bakteriestamme med antimikrobiel aktivitet anvendt på planter |
| AR101538A1 (es) * | 2014-09-25 | 2016-12-28 | Terragen Holdings Ltd | Cepas bacterianas que tienen actividad antimicrobiana y composiciones de biocontrol que las comprenden |
-
2018
- 2018-04-11 CN CN201880038209.3A patent/CN110753553A/zh active Pending
- 2018-04-11 SG SG11201908857Q patent/SG11201908857QA/en unknown
- 2018-04-11 US US16/604,325 patent/US20200376047A1/en not_active Abandoned
- 2018-04-11 JP JP2020505949A patent/JP7494110B2/ja active Active
- 2018-04-11 CA CA3059453A patent/CA3059453A1/en active Pending
- 2018-04-11 WO PCT/AU2018/050326 patent/WO2018187838A1/en not_active Ceased
- 2018-04-11 AU AU2018251616A patent/AU2018251616B2/en active Active
- 2018-04-11 EP EP18783729.9A patent/EP3609515A4/en active Pending
-
2024
- 2024-08-23 US US18/813,998 patent/US20250032563A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020516684A5 (enExample) | ||
| Schnupf et al. | Modulation of the gut microbiota to improve innate resistance | |
| Lin et al. | Impact of the gut microbiota, prebiotics, and probiotics on human health and disease | |
| JP2024129016A5 (enExample) | ||
| JP2024003162A (ja) | クロストリジウム・ディフィシル感染症の治療における新たな使用 | |
| RU2011139211A (ru) | Бактериальные штаммы, обладающие высокой противовоспалительной активностью | |
| Praet et al. | Bifidobacterium commune sp. nov. isolated from the bumble bee gut | |
| Vanmaele et al. | Characterization of the virulence of Harveyi clade vibrios isolated from a shrimp hatchery in vitro and in vivo, in a brine shrimp (Artemia franciscana) model system | |
| Dixon et al. | Evaluation of selected bacteria and yeast for probiotic potential in poultry production | |
| Cao et al. | First report of Pectobacterium parmentieri causing blackleg on potato in Inner Mongolia, China | |
| Handique et al. | First report of Pectobacterium punjabense causing blackleg and soft rot on potato in hebei and fujian province, China | |
| CN109157547A (zh) | 用于治疗抑郁症的乳酸菌复合菌剂 | |
| CN113564068A (zh) | 植物乳杆菌1201及其在制备抑制鼠伤寒沙门氏菌产品中的应用 | |
| CN112553115B (zh) | 植物乳杆菌zdy2013在制备缓解肾损伤产品中应用 | |
| Calo-Mata et al. | Intestinal microbiota: first barrier against gut-affecting pathogens | |
| CN118879583B (zh) | 一株具有免疫调节和降尿酸功能的植物乳植杆菌cn211及其应用 | |
| CN118383523B (zh) | 凝结芽孢杆菌bc07在制备增强免疫功能食品和/或免疫调节药物和/或抑菌剂方面的用途 | |
| JPH0930981A (ja) | 免疫賦活組成物 | |
| CN110591986B (zh) | 一株可缓解类风湿性关节炎的干酪乳杆菌及其应用 | |
| Huang et al. | Amplification of probiotic bacteria in the skin microbiome to combat Staphylococcus aureus infection | |
| JP6152231B1 (ja) | 腸内フローラ改善剤 | |
| KR20210067274A (ko) | 붉바리 양식용 미생물 제제 | |
| CN109385387A (zh) | 一种抗tgev的罗伊氏乳杆菌及其应用 | |
| CN115873765A (zh) | 一株类肠膜魏斯氏菌MbWp-1及其产品与应用 | |
| CN109362882A (zh) | 发酵乳杆菌cqpc07及其在制备改善溃疡性结肠炎的食品或药品中的应用 |